Recent news highlights Churchill Capital Corp XI’s SPAC deal with Agility Robotics, positioning it in the humanoid AI sector, and its status as a most active pre-market stock in June 2026. Other news items relate to broader biotech and robotics sectors.

• Churchill Capital Corp XI entered into a SPAC merger agreement with Agility Robotics, Inc., opening a door into humanoid AI technology [N2].
• The company was among the most active pre-market stocks on June 24, 2026, indicating market interest [N3].
• Other recent news items discuss broader biotech and robotics sector developments but do not provide direct updates on Churchill Capital Corp XI’s operations [N1,N4,N5,N6,N7,N8].

The company’s experienced Management Team and Operating Partners, combined with proprietary sourcing channels and strong industry relationships, provide a foundation for identifying attractive Business Combination targets. The Merger Agreement with Agility Robotics, Inc. opens access to the humanoid AI sector, potentially positioning the combined entity in a high-growth technology area. The company’s flexible capital structure and access to capital markets may facilitate efficient transaction execution and post-combination growth initiatives.

As a blank check company, Churchill Capital Corp XI has no operating revenues and depends entirely on completing an initial Business Combination to create shareholder value. The low liquidity ratio and significant net loss highlight financial constraints prior to the combination. Risks include failure to complete the Business Combination on favorable terms or within the Combination Period, potential conflicts of interest among management, and adverse market reactions. The company’s success is also subject to the performance and risks of the acquired business, which may be early-stage or financially unstable.

Churchill Capital Corp XI’s moat derives from its experienced Management Team and Operating Partners, who bring deep operational and transactional expertise across multiple sectors. The company leverages proprietary sourcing channels and extensive industry relationships, which provide a differentiated pipeline of acquisition opportunities. Its ability to structure complex transactions and access capital markets further supports its competitive position. However, as a blank check company without operating revenues or a completed Business Combination, its moat is contingent on successfully identifying and executing a value-creating acquisition.

• Completion Risk: The initial Business Combination may not be completed on the terms or timeline currently contemplated, or at all, which could adversely affect the company’s financial results and share price [S2].
• Financial Liquidity Risk: The company’s current ratio of 0.01 as of June 30, 2026, indicates very low liquidity, which may constrain operations and the ability to pursue the Business Combination [S2].
• Conflict of Interest Risk: Management and Sponsor may have conflicts of interest in selecting and negotiating the Business Combination, potentially affecting shareholder outcomes [S1].
• Market and Regulatory Risks: The company faces risks related to market reactions, regulatory approvals, and compliance with Nasdaq listing requirements, including potential delisting if the Business Combination is not completed timely [S1,S2].

• Churchill Capital Corp XI is a blank check company incorporated on June 4, 2025, as a Cayman Islands exempted company formed to effect a Business Combination with one or more businesses or entities [S1].
• The company completed its Initial Public Offering (IPO) on December 18, 2025, issuing 41,400,000 Public Units at $10.00 per unit, generating gross proceeds of $414 million, with $414 million placed in a Trust Account [S1].
• The IPO included 5,400,000 Option Units from the full exercise of the Over-Allotment Option and a private placement of 500,000 units to the Sponsor for $5 million [S1].
• Each Public Unit consists of one Public Share and one-tenth of one Public Warrant, with each whole warrant exercisable for one Class A Ordinary Share at $11.50 per share [S1].
• The company has not selected any specific Business Combination target as of the latest filings and has generated no operating revenues to date [S1].
• The Management Team is led by Michael Klein (CEO and Chairman) and Jay Taragin (CFO), supported by M. Klein and Company and Archimedes Advisors LLC, which includes Operating Partners with senior executive experience across multiple sectors [S1].
• The company’s strategy is to leverage its founder’s and partners’ experience and network to source, evaluate, and complete an initial Business Combination with a target company that has compelling growth prospects, competitive advantages, recurring revenue streams, and potential for operational improvements [S1].
• Investment criteria include sourcing through proprietary channels, benefiting from the company’s capabilities, having a committed management team, potential for stable free cash flow, and growth through acquisitions [S1].
• The company has a Combination Period to complete the initial Business Combination by December 18, 2027, with possible extensions subject to shareholder approval [S1].
• The company’s financial snapshot as of June 30, 2026, shows current assets of $1,614,098 and current liabilities of $139,867,555, resulting in a current ratio of 0.01, indicating very low liquidity [S2].
• Net income for the period ending June 30, 2026, was a loss of $134,680,744 [S2].
• The company issued an unsecured promissory note of up to $1,500,000 to its Sponsor on August 7, 2026, for working capital needs; the note is convertible into units at $10.00 per unit [S20].
• On June 24, 2026, Churchill Capital Corp XI entered into a Merger Agreement with Agility Robotics, Inc. to effect a business combination transaction [S20].
• The company’s Management Team and Operating Partners have experience in sourcing, structuring, acquiring, and operating businesses, and in accessing capital markets [S1].
• The company is classified as an emerging growth company and a smaller reporting company, with certain reduced disclosure obligations [S7,S8].
• The company’s public shares and warrants are listed on Nasdaq under symbols CCXI, CCXIU, and CCXIW [S20].
• The company’s business model and operations are focused on completing an initial Business Combination; it does not currently have operating revenues or products [S1].
• The company’s Management Team intends to devote necessary time to affairs until the initial Business Combination is completed [S1].
• The company’s competitive strengths include deep experience of Operating Partners, proprietary sourcing channels, investing experience, and execution and structuring capabilities [S4].
• The company’s acquisition process includes thorough due diligence, including meetings with management, document reviews, and inspection of facilities [S16].
• The company faces risks including the possibility that the initial Business Combination may not be completed on the contemplated terms or timeline, and that failure to complete the combination could adversely affect financial results and share price [S2].
• The company’s Sponsor and officers may have conflicts of interest related to the Business Combination process [S1].
• Recent news includes the company’s SPAC deal with Agility Robotics, opening a door into humanoid AI [N2], and the company being among the most active pre-market stocks on June 24, 2026 [N3].
• Other recent news items relate to broader biotech and robotics sectors but do not provide direct operational updates on Churchill Capital Corp XI [N1,N4-N8].